← Research library

Clinical effects of GB-115 in patients with Generalized Anxiety Disorder

Observational study · 2022

What was studied
25 patients; uncontrolled conference report
Main finding
A conference post-hoc analysis of 25 patients reported lower anxiety and fatigue scores over 21 days. Its relationship to the earlier pilot must be resolved before treating it as independent evidence.

Study data at a glance

Participants or experimental model
25 patients; uncontrolled conference report
Reported results
A conference post-hoc analysis of 25 patients reported lower anxiety and fatigue scores over 21 days. Its relationship to the earlier pilot must be resolved before treating it as independent evidence.
Study limitations and source details

Study limitations

  • Conference abstract, not a full clinical report.
  • No placebo comparison; possible overlap with the 31-patient pilot.

Related publications may describe some of the same participants or experiments.

Source details

Conference abstract

Selected original-source text checked; full methodological review pending.

Selected text reviewed

Sources checked

Citation

Uncontrolled human reportFull text available

Author unconfirmed. Clinical effects of GB-115 in patients with Generalized Anxiety Disorder European Psychiatry. 65(Suppl 1):S388

Study source ↗ · DOI 10.1192/j.eurpsy.2022.981 · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards